drugset / Trial / NCT04101474

Role Of Ketamine in Treatment-Resistant Major Depressive Disorder And Its Effect on Suicidality

NCT04101474 ↗

Completed 36 enrolled Assiut University
RandomizedParallel-groupTriple-blindTreatment

Summary

In this study we will assess the effect of Ketamine infusion on depressive symptoms and in particular its effect on Suicidal behavior, ideation and thoughts in patients with treatment- resistant MDD.

Timeline

Start
2020-09-01
Primary completion
2021-10-01
Completion
2021-10-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 0.5 mg/kg Intravenous

Indications

No indication recorded.